- PDMR Notification
- March 2024 Quarter Activity Report
- Dr. Shlomo Sadoun Joins Advisory Board
- Suspension - MGC Pharmaceuticals Limited
- Change of name to Argent BioPharma Limited
- Refinancing of Convertible Securities Agreement
- Results of General Meeting
- Half-year Report
- Update - Application for Admission to Trading
- Dispatch of General Meeting Documents
More ▼
Key statistics
As of last trade, Argent Biopharma Ltd (RGT:ASX) traded at 0.375, 25.00% above the 52 week low of 0.300 set on Jan 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.39 |
---|---|
High | 0.39 |
Low | 0.375 |
Bid | 0.375 |
Offer | 0.38 |
Previous close | 0.395 |
Average volume | 10.01k |
---|---|
Shares outstanding | 45.28m |
Free float | 12.23m |
P/E (TTM) | -- |
Market cap | 17.89m AUD |
EPS (TTM) | -3.32 AUD |
Data delayed at least 20 minutes, as of May 03 2024 02:15 BST.
More ▼